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Surgery of atrial ﬁbrillation (AF) was ﬁrst described in 1991 by James Cox in what was named the Cox-Maze procedure, and over
the years it has been considered the gold-standard treatment, with best results in maintaining sinus rhythm in the long term.
Nevertheless, the complexity and aggressivity of the ﬁrst techniques of cut-and-sew limited the application of this procedure, and
few centers were dedicated to AF surgery. In the past years, however, new devices able to ablate atrial tissue with cryotherapy,
radiofrequency, or ultrasounds have facilitated this operation. In the mid-term, other energy devices with laser or microwave have
been abandoned due to a lack of consistency in getting transmural lesions in a consistent and reproducible manner. Additionally,
better knowledge of the physiopathology of AF, with the importance of triggering zones around the pulmonary veins, has started
new minimallyinvasive techniques to approach paroxysmaland persistent AF patients through thoracoscopy.
1.Introduction
Atrial ﬁbrillation (AF) is the most common cardiac arrhyth-
mia, aﬀecting 1% of the general population and with its
prevalence increasing with age [1]. Most important, AF
has well-documented consequences as disabling symptoms,
elevated stroke risk and major risk of congestive cardiac
failure, being an independent predictor of death [2]. In
summary, it represents a high cost on the health public
systems of most developed countries.
Surgeons were the ﬁrst ones to treat AF eﬀectively and
reverse it to sinus rhythm. James Cox described a series of
surgical procedures known as Cox-Maze technique, between
1988 and 1991, that crystallized in the Cox-Maze III. This
surgical approach was directed to divide both right and left
atria by a series of cuts and sutures to redirect the electrical
impulse to close-end paths, to ﬁnalize atrial depolarization,
and be ready for the next sinus node impulse. This operation
also included the exclusion of both atrial appendages and
the isolation of the four pulmonary veins and the posterior
wall of the left atrium. Although very eﬀective, with over
91% patients maintaining sinus rhythm at 10 years, few
surgical groups performed the Cox-Maze procedure due to
the aggressiveness of it, with long suture lines and prolonged
myocardial ischemic times [3, 4].
In the last decade, three factors have changed the
approach of surgeons to AF: ﬁrst, a better understanding of
the electrophysiological basis of AF. In 1998, Haissaguerre
described that most patients with paroxysmal AF have
electric triggering zones localized within the antrum of
the pulmonary veins [5], and that isolation of these areas
was able to control AF eﬀectively. However, later studies
have demonstrated that pulmonary vein isolation alone was
insuﬃcient to control persistent or long-standing persistent
AF and that a maze approach is needed to be added in these
patients. Also, multiple studies have shown better results
when the maze procedure was applied biatrially, compared
to when only the left atrium is approached [6].
The second factor has been the development of new
surgical tools able to create a similar lesion set of the Cox-
Maze procedure faster and less aggressively, but maintain-
ing a consistent, transmural, and linear lesions. Initially,
these were clamps or catheters delivering heat or cold,
with microwave ultrasounds, radiofrequency, laser, or liquid
nitrogen, and argon, respectively. Nowadays, cryotherapy,
bipolar radiofrequency, and ultrasounds are the most used
energy sources and are recognized as a useful treatment
by the 2010 Guidelines of the European Society of Car-
diology (ESC) together with the European Association of2 Cardiology Research and Practice
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Figure 1: (a) Cox-Maze III: Lesion pattern described by James Cox in 1991 with cut and sew technique. (b) Cox-Maze IV: Similar lesion
pattern, with alternative energy lesion in dotted lines and trying to minimize incisions in both atria. Only the left appendage is excised.
Cardiothoracic Surgeons (EACTS) and the European Heart
Rhythm Association (EHRA) [7, 8].
Finally, there has been increasing scientiﬁc evidence
concerning cardiac surgeons of the deleterious eﬀects of
AF in cardiac patients and the importance of treating
this arrhythmia. Recent studies relate preoperative AF with
worse survival rates after valvular or coronary surgery [9].
Furthermore, patients with successful maze procedures have
shown better long-term survival rates, higher freedom from
stroke, and thromboembolic events, improved ventricular
ejection fraction and exercise tolerance [7].
All the above factors have expanded the indications for
the surgical treatment of concomitant AF to most patients
with coronary or valvular surgery. For patient with long-
standing persistent AF, the Cox-Maze procedure is still the
gold standard treatment with the best results at 10- and 15-
year followup.
2.CurrentSurgicalStrategies
The initial Cox-Maze III operation (“Cut-and-sew tech-
nique”) described by James Cox consists in multiple biatrial
lesions that interrupt the multiple reentrant circuits and
redirects the sinus impulse to the atrioventricular node. This
technique has shown excellent results, with over 90% sinus
rhythm restoration over 15 years, although the initial series
included a large percentage of patients with paroxysmal AF.
When applied to long-standing AF concomitant to valvular
disease, this technique has shown a 75–80% success rates. As
seen in Figure 1(a), this operation includes several features.
First, it isolates all pulmonary veins and the posterior wall of
the left atrium. Second, it interferes in all concentric atrial
structures that can facilitate atrial ﬂutter. Those are, in the
left side, the mitral annulus and the left appendage, and, in
the right side, the entrance of both the superior and inferior
venae cavae, the tricuspid annulus and the right appendage.
Third, the procedure ﬁnishes with the excision of right and
left appendages, the later to avoid the main source of atrial
thrombi. The most important lines are the one connecting
the pulmonary veins with the mitral annulus, to avoid left
atrial ﬂutter, and the line to the tricuspid annulus [10].
As main setbacks of this operation, besides the need
for long incisions that need to be sewed back prolonging
myocardial ischemia and extracorporeal circulation times,
between 45 minutes and 1 hour, were the need of pacemaker
in 10% of patients, and a certain degree of chronic ﬂuid
retention in some patients, attributed to a lack of natriuretic
peptide secretion induced by bilateral appendage amputa-
tion.
Nowadays, most surgeons apply diﬀerent energy sources
to perform the Cox-Maze procedure, then naming it Cox-
Maze IV (Figure 1(b)). Heat-based energy sources include
bipolar radiofrequency or ultrasounds. Cryotherapy can be
applied using liquid nitrogen or argon. To create eﬀective
lesions that block the electrical impulse, the temperature
applied to the tissue must reach 60◦Co rm i n u s6 5 ◦C
during two minutes to create ﬁbrosis. Instruments have been
designed in the form of long clamps to create a consistent
transmural lesionlinewithoutcausing injury tosurrounding
tissues. Other energy types initially described, as microwave
ormonopolarradiofrequency,wereabandonedduetolackof
consistenttransmurallesionsorbyincreasedriskofcollateral
injuries. But, besides diﬀerent instrumentation, the actual
lesion pattern remains basically the one described by CoxCardiology Research and Practice 3
in 1991, with few exceptions. First, most surgeons avoid
the atrial septal lesion, making this procedure no longer
associated with a higher need of pacemaker implantation
thanwhat itisassociated towhateverconcomitantprocedure
is coupled with. Second, to avoid possible deﬁcit of atrial
natriuretic peptide production, only the left appendage is
excluded.
The direct vision of the heart and the rapid creation of
transmural lesions with these techniques add only 15 to 30
minutes to the surgical time. Surgeons tend to minimize the
cut and sew lesions to the ones needed to access the atria,
trying to perform the maximum number of lines with cold
or heat therapies. Several techniques have been described to
avoid coronary artery injuries when approaching the mitral
and tricuspid annulus.
When indicating a surgical therapy to AF, factors inﬂu-
encing success rate must be foreseen. These include atrial
dilatation, age, years in AF, and type of AF (paroxysmal,
persistent, or long-standing persistent). Probably the most
important is atrial dilatation, due to chronic AF of by
valvular dysfunction [11]. Scientiﬁc evidence shows that
Cox-Maze procedure is less eﬀective when left atrial postero-
anterior diameter reaches 60mm, and even when eﬀective,
atrial electrical stimuli transport usually is impaired. Type
of AF is also an important condition for success rates.
While pulmonary vein isolation has showed good results in
patients with paroxysmal atrial ﬁbrillation, persistent and
long-standing persistent patients beneﬁt from the complete
biatrial lesion set in order to get sinus rhythm maintenance
over 80% at 10 years. Therefore, surgical approach must be
tailored in these patients [12].
3.Minimally Invasive Techniquesfor
Isolated AF
With the development of new energy sources for atrial
ﬁbrillation and a better knowledge of the pathophysiology of
AF, diﬀerent surgical instruments have been created to allow
a minimal invasive approach and eﬀectively treat AF without
big thoracic incisions. Energy is applied epicardially through
direct vision with clamps that allow long transmural lesions.
Moreover, epicardial ganglionic plexi around the pulmonary
veins can be identiﬁed and ablated, and the left appendage
excised or clipped to minimize thromboembolic events.
In 2005, Wolf published a series of 27 patients with
pulmonary vein ablation with epicardially applied bipolar
radiofrequencyandleftappendageexclusion.Thisprocedure
was named Mini-Maze IV (Figures 2 and 3). The sinus
rhythm was restored in 91% of patients with previous
paroxysmal AF, without mortality and a low morbidity. The
procedure was performed through bilateral 5cm thoraco-
tomy incisions and video-thoracoscopyassistance [13]. Later
on, this operation has evolved to a totally thoracoscopic
technique, with three 1cm incisions in each side. Moreover,
new connecting lesions from the right to the left superior
veins and to the mitral annulus have been described to treat
persistent AF patients [14, 15].
Figure 2: Pulmonary vein ablation by bipolar radiofrequency
through a thoracoscopic approach. The ablation line can be seen
in the left atrium at the antrum of the pulmonary veins.
Figure 3: New clip device to close the left atrial appendage through
sternotomy or thoracoscopic approaches.
These procedures have shown especially good results in
patients with failed previous catheter ablation. In our series
of 61 patients of pulmonary vein isolation with bipolar
radiofrequency, postoperative sinus rhythm was maintained
in 82% paroxysmal, 60% persistent, and 20% long-standing
persistent AF patients at 12 months. LA size >45mm and
AF type showed to be preoperative factors that signiﬁcantly
inﬂuenced outcome [16]. The recent 2010 Guidelines of the
ESC and EACTS recommends, minimally invasive surgical
ablation of AF without concomitant cardiac surgery to
patients with lone symptomatic AF after failure of catheter
ablation [7, 8].
4.Conclusions
With better knowledge of the physiopathology of AF and
easier access to energy sources that create consistent trans-
mural lesions, surgery of atrial ﬁbrillation has made a great
impulse from the early days when Cox ﬁrst described his
Maze procedure. Concomitant surgical AF treatment has
shown better survival rate, higher freedom from stroke and
thromboembolic events, better ventricular function, and
better exercise tolerance. Still, success rates are lower in
patients with long history of AF, usually with enlarged atria,
long-standing persistent AF pattern, and olderage. Probably,4 Cardiology Research and Practice
the alteration of the atrial substrate, with more ﬁbrotic tissue
and established macro-reentrant circuits may limit maze
strategies in these patients.
In addition, minimally invasive approaches have been
described in the last ﬁve years with very good results for iso-
lated paroxysmal or persistent AF. Nevertheless, prospective
randomized trials are necessary to conﬁrm their long-term
results, compared to catheter ablation.
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